Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 461

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 461
---
 elects to account for this investment using the measurement alternative. For the year ended December31, 2024, 2023 and 2022, re-measurement gain amounted to $nil, $ and $, have been made to the investment in Alzheon according to the most recent transaction price which were deemed as observable price changes in orderly transactions for the identical or similar investment of the same issuer. The carrying value of the investment with Alzheon was $ and $ as of December31, 2024 and 2023, respectively.

The Group recorded $ million and $ million impairment for two investments the year ended December 31, 2024 and 2022 since the Group considered the investees’ ability to continue as a going concern and the investment is not recoverable. The carrying value of these two investments was $nil and $ as of December31, 2024 and 2023, respectively

The Group did not sell any non-marketable investments or recorded any realized gains or losses for the non-marketable investments measured at fair value on a non-recurring basis during the years ended December 31, 2024, 2023 and 2022.

The following table summarizes the total carrying value of the non-marketable investments held as of December 31, 2024 and 2023 including cumulative unrealized upward and downward adjustments and impairment made to the initial cost basis of the investments:

|                                             |     |   | December 31, 
         2024 |   |     |   | December 31, 
         2023 |   |
|:--------------------------------------------|:----|:--|-------------:|:--|:----|:--|-------------:|:--|
| Initial cost basis                          |     | $ |    4,079,707 |   |     | $ |    4,079,707 |   |
| Upward adjustments                          |     |   |   12,539,960 |   |     |   |   12,539,960 |   |
| Downward adjustments                        |     |   |            — |   |     |   |            — |   |
| Impairment                                  |     |   |   (1,520,821 | ) |     |   |     (520,821 | ) |
| Total carrying value at the end of the year |     | $ |   15,098,846 |   |     | $ |   16,098